Advances in hypertension as reported at ACC 2025 include two new therapies that achieve significant blood pressure (BP) reduction, and a comparison of renal denervation methods for resistant BP.

A new technique to mark peripheral pulmonary lesions (PPLs) before surgical resection was studied by Ganesh Krishna, M.D., a ...

Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.

The Pulmonary Hypertension Association has launched a new certificate program for advanced practice providers and allied health professionals. The Pulmonary Hypertension Certificate program is ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

E-cigarette use is linked to increased risk of COPD and possibly hypertension, though less harmful than traditional smoking, ...

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

Mendelian randomization (MR) represents a valuable methodology to address the causal relationships between an exposure and an ...

Original Medicare and Part C should provide a comprehensive pulmonary rehabilitation program for a person who has chronic issues with breathing. Original Medicare includes Part A, which is ...